Bile acids exacerbate liver cancer, UDCA may offer relief, highlights study Dr. Kamal Kant Kohli15 Jan 2025 9:30 PM ISTImmunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors. It has made an incredible impact...
Medical Bulletin 19/ October/ 2024 Dr. Bhumika Maikhuri19 Oct 2024 3:00 PM ISTHere are the top medical news for the day:Quality of Diet May Reduce Chances of Prostate Cancer Progression During Active SurveillanceA research team...
Predictive Biomarker May Help Identify Patients Who Could Benefit from Immunotherapy in Liver Cancer Cases: Study Dr. Bhumika Maikhuri19 Oct 2024 8:45 AM ISTIt may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy,...
Medical Bulletin 04/ October/ 2024 Dr. Bhumika Maikhuri4 Oct 2024 3:00 PM ISTHere are the top medical news for the day:Higher Prevalence of Mental Disorder and Suicidality Among Transgender When Compared to Cisgender...
Obesity and Diabetes May Be Risk Factors for Recurrence of Hepatocellular Carcinoma, Study Reveals Dr. Bhumika Maikhuri4 Oct 2024 8:00 AM ISTA recent study has highlighted that the coexistence of obesity and Diabetes mellitus increased late recurrence and worsened prognosis in patients with...
Diabetes and obesity tied to Increased risk of liver cancer relapse after resection: Study Dr. Kamal Kant Kohli4 Oct 2024 2:00 AM ISTHepatocellular carcinoma, a type of liver cancer associated with hepatitis infections, is known to have a high recurrence rate after cancer removal....
Pitt study identifies potential new treatment for liver fibrosis Dr. Kamal Kant Kohli2 Oct 2024 8:00 PM ISTNew research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis and suggests a novel...
Neoadjuvant immunotherapy facilitates surgery and improves outcomes for patients with high-risk liver cancer: Study Dr. Kamal Kant Kohli6 Sept 2024 8:30 PM ISTPatients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery-including those who would not have been eligible for...
USFDA accepts application for Opdivo plus Yervoy for unresectable hepatocellular carcinoma Ruchika Sharma22 Aug 2024 4:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License...
Medical Bulletin 31/ July/ 2024 Anshika Mishra31 July 2024 3:00 PM ISTHere are the top medical news for the day:Healthy Diet Low in Sugar Linked to Younger Biological Age: JAMA StudyResearchers at UC San Francisco have...
Are Non-Statin Cholesterol-Lowering Medications Linked to Liver Cancer? Study Sheds light Anshika Mishra31 July 2024 8:30 AM ISTPrimary liver cancer is the sixth most common cancer worldwide and the third leading cause of cancer deaths. Major risk factors for liver cancer...
Do non-statin cholesterol-lowering drugs affect liver cancer risk? Dr. Kamal Kant Kohli31 July 2024 6:15 AM ISTPast studies have suggested that taking cholesterol-lowering statin drugs may lower individuals' risk of developing liver cancer. In a new study of...
